Tinubu appoints 3 new NUPRC Executive Commissioners


President Bola Tinubu has approved the appointment of three new Executive Commissioners to serve in the Nigerian Upstream Petroleum Regulatory Commission (NUPRC), and the redeployment of one current Executive Commissioner, pending their confirmation by the Nigerian Senate.

According to a Statement Tuesday signed by Ajuri Ngelale, Special Adviser to the President (Media & Publicity), those appointed include: Mr. Bashir Indabawa (NW) Executive Commissioner, Exploration & Acreage Management; Dr. Kelechi Ofoegbu (SE) Executive Commissioner, Corporate Services & Administration (Redeployed); Mr. Enorense Amadasu — SS — Executive Commissioner, Development & Production and Mr. Babajide Fasina (S) — Executive Commissioner, Economic Regulation & Strategic Planning.


Ngelale further said: “The President approves this reshuffling and replacement based on his deeply informed assessment of all factors concerning the sector with a view to establishing a regulatory framework and culture that comprehensively disincentivizes errant behaviour and incentivizes diligence and rules-based business practice across the industry.”

President Bola Tinubu had earlier in the day approved the appointment of Dr. Abdu Mukhtar to serve as the National Coordinator of the Presidential ‘Unlocking Healthcare Value-Chain’ Initiative, which is domiciled under the Federal Ministry of Health & Social Welfare.

Ajuri Ngelale, Special Adviser to the President (Media & Publicity) disclosed this in a statement Tuesday.

Ngelale said the strategic approval seeks to unlock billions of dollars of new investment into the nation’s healthcare-delivery system through a time-bound and cross-ministerial collaboration to restructure the ecosystem of Health Product manufacturing, Health Logistics services, Health Technology services, Health Retail services (e-Commerce), Health Provider facilitation, and Health Payor reform (Third Party Administrators & Insurers)

This he said further has been done in order to achieve: measurable increase in the domestic manufacturing of generic pharmaceuticals, vaccines, biologics, and devices; reduction of outbound medical tourism by enhancing service quality in Nigeria while catalyzing alternative health ecosystems in-country;

and measurable increase in quantity of quality jobs across the value chain through enhanced FDI and local capital mobilization.

Dr. Mukhtar comes to the task as the immediate past Director of Industry & Trade Development at the African Development Bank (AfDB).

Prior to joining the AfDB, Dr. Mukhtar served as the Group Chief Strategy Officer of the Dangote Group of Industries, where he played a key role in the conglomerate’s expansion of its cement production footprint into fourteen African countries, in addition to important joint ventures in the power, oil & gas, and agriculture sectors. This followed a four-year tenure as the Chief Executive Officer of the FCTA’s Abuja Investment Company Limited from 2007 to 2011.

Dr. Mukhtar holds a Doctorate in Biotechnology from Boston University (USA); a Masters in Business Administration from Harvard Business School (USA); a Masters in Public Policy from Harvard’s Kennedy School of Government, and a Medical Degree from Ahmadu Bello University, Zaria.

According to Ngelale, the President expects that the National Coordinator of this new cross-ministerial initiative will bring to bear his vast experience and academic qualifications in the effective execution of this essential national assignment such that the massive economic boon represented by Nigeria’s healthcare-delivery system can move from potential and theory into reality and practice in accordance with the Renewed Hope Agenda of his administration.


Leave a Reply

Your email address will not be published. Required fields are marked *